STOCK TITAN

[Form 3] Nuvalent, Inc. Initial Statement of Beneficial Ownership

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
3
Rhea-AI Filing Summary

Form 3 Overview: Nuvalent, Inc. (NUVL) filed an Initial Statement of Beneficial Ownership for Ms. Christy J. Oliger on 06/20/2025, reporting an event date of 06/18/2025.

Key Details:

  • Reporting Person: Christy J. Oliger
  • Relationship to Issuer: Director (no other roles indicated)
  • Beneficial Ownership: The filer explicitly states “No securities are beneficially owned.”
  • Filing Type: Form filed by one reporting person; accompanied by a Power of Attorney (Exhibit 24) signed by attorney-in-fact Nathan N. McConarty.

Investor Takeaway: A Form 3 signals an insider’s entry into the company’s reporting framework. However, because the form shows zero shares owned, there is no immediate dilution, concentration change, or valuation signal. The filing is largely administrative, confirming Ms. Oliger’s board position and future reporting obligations under Section 16(a).

Panoramica del Modulo 3: Nuvalent, Inc. (NUVL) ha presentato una Dichiarazione Iniziale di Proprietà Beneficiaria per la Sig.ra Christy J. Oliger il 20/06/2025, riferendo un evento datato 18/06/2025.

Dettagli Principali:

  • Persona che Riporta: Christy J. Oliger
  • Rapporto con l’Emittente: Direttrice (nessun altro ruolo indicato)
  • Proprietà Beneficiaria: Il dichiarante specifica esplicitamente “Nessun titolo è posseduto in via beneficiaria.”
  • Tipo di Presentazione: Modulo presentato da una sola persona; accompagnato da una Procura (Allegato 24) firmata dall’avvocato rappresentante Nathan N. McConarty.

Considerazioni per gli Investitori: Un Modulo 3 indica l’ingresso di un insider nel sistema di rendicontazione della società. Tuttavia, poiché il modulo mostra zero azioni possedute, non vi è alcuna diluizione immediata, variazione nella concentrazione o segnale di valutazione. La presentazione è prevalentemente amministrativa, confermando la posizione di Ms. Oliger nel consiglio e gli obblighi futuri di rendicontazione ai sensi della Sezione 16(a).

Resumen del Formulario 3: Nuvalent, Inc. (NUVL) presentó una Declaración Inicial de Propiedad Beneficiaria para la Sra. Christy J. Oliger el 20/06/2025, reportando un evento fechado el 18/06/2025.

Detalles Clave:

  • Persona que Reporta: Christy J. Oliger
  • Relación con el Emisor: Directora (sin otros roles indicados)
  • Propiedad Beneficiaria: El declarante afirma explícitamente “No se poseen valores en forma beneficiaria.”
  • Tipo de Presentación: Formulario presentado por una sola persona; acompañado por un Poder Notarial (Anexo 24) firmado por el apoderado Nathan N. McConarty.

Conclusión para Inversores: Un Formulario 3 señala la entrada de un insider en el marco de reportes de la empresa. Sin embargo, dado que el formulario muestra cero acciones en propiedad, no hay dilución inmediata, cambio en la concentración o señal de valoración. La presentación es principalmente administrativa, confirmando el puesto de la Sra. Oliger en la junta y sus futuras obligaciones de reporte bajo la Sección 16(a).

서식 3 개요: Nuvalent, Inc. (NUVL)은 2025년 6월 20일에 Christy J. Oliger 씨에 대한 초기 수익 소유권 신고서를 제출했으며, 사건 일자는 2025년 6월 18일로 보고되었습니다.

주요 내용:

  • 신고인: Christy J. Oliger
  • 발행회사와의 관계: 이사 (기타 역할 없음)
  • 수익 소유권: 신고인은 명확히 “수익적으로 소유한 증권이 없습니다.”라고 명시했습니다.
  • 제출 유형: 한 명의 신고인이 제출한 서식; 법정대리인 Nathan N. McConarty가 서명한 위임장(첨부문서 24) 포함.

투자자 참고사항: 서식 3은 내부자가 회사의 보고 체계에 진입했음을 알립니다. 그러나 서식에 보유 주식이 전혀 없으므로 즉각적인 희석, 집중도 변화 또는 가치 평가 신호가 없습니다. 이 제출은 주로 행정적 절차로, Oliger 씨의 이사회 직위와 섹션 16(a)에 따른 향후 보고 의무를 확인하는 내용입니다.

Présentation du Formulaire 3 : Nuvalent, Inc. (NUVL) a déposé une Déclaration Initiale de Possession Bénéficiaire pour Mme Christy J. Oliger le 20/06/2025, signalant un événement daté du 18/06/2025.

Détails Clés :

  • Personne Déclarant : Christy J. Oliger
  • Relation avec l’Émetteur : Administratrice (aucun autre rôle indiqué)
  • Possession Bénéficiaire : La déclarant précise explicitement « Aucun titre n’est détenu à titre bénéficiaire. »
  • Type de Dépôt : Formulaire déposé par une seule personne ; accompagné d’une Procuration (Annexe 24) signée par le mandataire Nathan N. McConarty.

Points à Retenir pour les Investisseurs : Un Formulaire 3 indique l’entrée d’un initié dans le cadre de déclaration de la société. Cependant, comme le formulaire indique aucune action détenue, il n’y a aucune dilution immédiate, changement de concentration ou signal d’évaluation. Le dépôt est principalement administratif, confirmant la position de Mme Oliger au conseil et ses futures obligations de déclaration selon la Section 16(a).

Überblick über Formular 3: Nuvalent, Inc. (NUVL) reichte am 20.06.2025 eine Erstmeldung über wirtschaftliches Eigentum für Frau Christy J. Oliger ein, mit einem Ereignisdatum vom 18.06.2025.

Wichtige Details:

  • Melder: Christy J. Oliger
  • Beziehung zum Emittenten: Direktorin (keine weiteren Rollen angegeben)
  • Wirtschaftliches Eigentum: Die Melderin gibt ausdrücklich an „Es werden keine Wertpapiere wirtschaftlich gehalten.“
  • Art der Einreichung: Formular eingereicht von einer meldenden Person; begleitet von einer Vollmacht (Anlage 24), unterschrieben vom Bevollmächtigten Nathan N. McConarty.

Investorenausblick: Ein Formular 3 signalisiert den Einstieg eines Insiders in das Berichtssystem des Unternehmens. Da jedoch keine Aktien gehalten werden, gibt es keine unmittelbare Verwässerung, Konzentrationsänderung oder Bewertungssignale. Die Einreichung ist hauptsächlich administrativer Natur und bestätigt Frau Oligers Vorstandsposten sowie ihre zukünftigen Meldepflichten gemäß Abschnitt 16(a).

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Routine Form 3; new director discloses zero share ownership—administrative, not financially material.

The filing merely registers Christy Oliger as a Section 16 insider. Because she holds no equity, the document carries negligible financial weight: it neither signals confidence via share purchases nor raises dilution concerns. It does, however, establish transparency for future trades. Unless follow-on Form 4 filings document stock awards or purchases, investors can treat this as non-impactful housekeeping.

Panoramica del Modulo 3: Nuvalent, Inc. (NUVL) ha presentato una Dichiarazione Iniziale di Proprietà Beneficiaria per la Sig.ra Christy J. Oliger il 20/06/2025, riferendo un evento datato 18/06/2025.

Dettagli Principali:

  • Persona che Riporta: Christy J. Oliger
  • Rapporto con l’Emittente: Direttrice (nessun altro ruolo indicato)
  • Proprietà Beneficiaria: Il dichiarante specifica esplicitamente “Nessun titolo è posseduto in via beneficiaria.”
  • Tipo di Presentazione: Modulo presentato da una sola persona; accompagnato da una Procura (Allegato 24) firmata dall’avvocato rappresentante Nathan N. McConarty.

Considerazioni per gli Investitori: Un Modulo 3 indica l’ingresso di un insider nel sistema di rendicontazione della società. Tuttavia, poiché il modulo mostra zero azioni possedute, non vi è alcuna diluizione immediata, variazione nella concentrazione o segnale di valutazione. La presentazione è prevalentemente amministrativa, confermando la posizione di Ms. Oliger nel consiglio e gli obblighi futuri di rendicontazione ai sensi della Sezione 16(a).

Resumen del Formulario 3: Nuvalent, Inc. (NUVL) presentó una Declaración Inicial de Propiedad Beneficiaria para la Sra. Christy J. Oliger el 20/06/2025, reportando un evento fechado el 18/06/2025.

Detalles Clave:

  • Persona que Reporta: Christy J. Oliger
  • Relación con el Emisor: Directora (sin otros roles indicados)
  • Propiedad Beneficiaria: El declarante afirma explícitamente “No se poseen valores en forma beneficiaria.”
  • Tipo de Presentación: Formulario presentado por una sola persona; acompañado por un Poder Notarial (Anexo 24) firmado por el apoderado Nathan N. McConarty.

Conclusión para Inversores: Un Formulario 3 señala la entrada de un insider en el marco de reportes de la empresa. Sin embargo, dado que el formulario muestra cero acciones en propiedad, no hay dilución inmediata, cambio en la concentración o señal de valoración. La presentación es principalmente administrativa, confirmando el puesto de la Sra. Oliger en la junta y sus futuras obligaciones de reporte bajo la Sección 16(a).

서식 3 개요: Nuvalent, Inc. (NUVL)은 2025년 6월 20일에 Christy J. Oliger 씨에 대한 초기 수익 소유권 신고서를 제출했으며, 사건 일자는 2025년 6월 18일로 보고되었습니다.

주요 내용:

  • 신고인: Christy J. Oliger
  • 발행회사와의 관계: 이사 (기타 역할 없음)
  • 수익 소유권: 신고인은 명확히 “수익적으로 소유한 증권이 없습니다.”라고 명시했습니다.
  • 제출 유형: 한 명의 신고인이 제출한 서식; 법정대리인 Nathan N. McConarty가 서명한 위임장(첨부문서 24) 포함.

투자자 참고사항: 서식 3은 내부자가 회사의 보고 체계에 진입했음을 알립니다. 그러나 서식에 보유 주식이 전혀 없으므로 즉각적인 희석, 집중도 변화 또는 가치 평가 신호가 없습니다. 이 제출은 주로 행정적 절차로, Oliger 씨의 이사회 직위와 섹션 16(a)에 따른 향후 보고 의무를 확인하는 내용입니다.

Présentation du Formulaire 3 : Nuvalent, Inc. (NUVL) a déposé une Déclaration Initiale de Possession Bénéficiaire pour Mme Christy J. Oliger le 20/06/2025, signalant un événement daté du 18/06/2025.

Détails Clés :

  • Personne Déclarant : Christy J. Oliger
  • Relation avec l’Émetteur : Administratrice (aucun autre rôle indiqué)
  • Possession Bénéficiaire : La déclarant précise explicitement « Aucun titre n’est détenu à titre bénéficiaire. »
  • Type de Dépôt : Formulaire déposé par une seule personne ; accompagné d’une Procuration (Annexe 24) signée par le mandataire Nathan N. McConarty.

Points à Retenir pour les Investisseurs : Un Formulaire 3 indique l’entrée d’un initié dans le cadre de déclaration de la société. Cependant, comme le formulaire indique aucune action détenue, il n’y a aucune dilution immédiate, changement de concentration ou signal d’évaluation. Le dépôt est principalement administratif, confirmant la position de Mme Oliger au conseil et ses futures obligations de déclaration selon la Section 16(a).

Überblick über Formular 3: Nuvalent, Inc. (NUVL) reichte am 20.06.2025 eine Erstmeldung über wirtschaftliches Eigentum für Frau Christy J. Oliger ein, mit einem Ereignisdatum vom 18.06.2025.

Wichtige Details:

  • Melder: Christy J. Oliger
  • Beziehung zum Emittenten: Direktorin (keine weiteren Rollen angegeben)
  • Wirtschaftliches Eigentum: Die Melderin gibt ausdrücklich an „Es werden keine Wertpapiere wirtschaftlich gehalten.“
  • Art der Einreichung: Formular eingereicht von einer meldenden Person; begleitet von einer Vollmacht (Anlage 24), unterschrieben vom Bevollmächtigten Nathan N. McConarty.

Investorenausblick: Ein Formular 3 signalisiert den Einstieg eines Insiders in das Berichtssystem des Unternehmens. Da jedoch keine Aktien gehalten werden, gibt es keine unmittelbare Verwässerung, Konzentrationsänderung oder Bewertungssignale. Die Einreichung ist hauptsächlich administrativer Natur und bestätigt Frau Oligers Vorstandsposten sowie ihre zukünftigen Meldepflichten gemäß Abschnitt 16(a).

SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Oliger Christy J.

(Last) (First) (Middle)
C/O NUVALENT, INC.
ONE BROADWAY, 14TH FLOOR

(Street)
CAMBRIDGE MA 02142

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
06/18/2025
3. Issuer Name and Ticker or Trading Symbol
Nuvalent, Inc. [ NUVL ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
Exhibit 24: Power of Attorney
No securities are beneficially owned.
/s/ Nathan N. McConarty, attorney-in-fact 06/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Why did Nuvalent (NUVL) file a Form 3 for Christy J. Oliger?

The SEC requires a Form 3 when an individual becomes a director, officer, or 10% owner; Ms. Oliger has joined Nuvalent’s board.

How many Nuvalent shares does Christy Oliger currently own?

Zero. The Form 3 states that no securities are beneficially owned.

Does the Form 3 indicate any upcoming share issuance or dilution for NUVL?

No. The filing is administrative and reports no derivative or non-derivative securities owned.

What is the event date referenced in the Form 3 for NUVL?

06/18/2025—this marks the date Ms. Oliger became a Section 16 reporting insider.

Who signed the Form 3 on behalf of Christy Oliger?

Nathan N. McConarty signed as attorney-in-fact, per the attached Power of Attorney.
Nuvalent, Inc.

NASDAQ:NUVL

NUVL Rankings

NUVL Latest News

NUVL Latest SEC Filings

NUVL Stock Data

5.78B
62.83M
2.9%
108.09%
7.75%
Biotechnology
Pharmaceutical Preparations
Link
United States
CAMBRIDGE